Health-economic Evaluation of a Universal Digital Stress Management Intervention for Employees Alongside a Randomized Controlled Trial (Preprint)

Author:

Freund JohannaORCID,Smit FilipORCID,Lehr DirkORCID,Zarski Anna-CarlottaORCID,Berking MatthiasORCID,Riper HeleenORCID,Funk BurkhardtORCID,Ebert David DanielORCID,Buntrock ClaudiaORCID

Abstract

BACKGROUND

Stress is highly prevalent and known to be a risk factor for a wide range of physical and mental disorders. The effectiveness of digital stress management interventions has been confirmed; however, research on its economic merits is still limited.

OBJECTIVE

To assess the cost-effectiveness, cost–utility, and cost-benefit of a universal digital stress management intervention for employees compared to a waitlist control condition within a time horizon of 6 months.

METHODS

Recruitment was directed at the German working population. A sample of 396 employees was randomly assigned to the intervention group (n = 198) or the waiting list control (WLC) group (n = 198). The digital stress management intervention included seven sessions plus one booster session and was offered without therapeutic guidance. Health service use, patient and family expenditures, and productivity losses were self-assessed and used for costing from a societal and an employer’s perspective. Costs were related to symptom-free status (PSS-10 score 2 standard deviations below the study population baseline mean) and quality-adjusted life years (QALYs) gained. Sampling error was handled using nonparametric bootstrapping.

RESULTS

From a societal perspective, the digital intervention had a 56% (55%) probability of being cost-effective at a willingness-to-pay of €0 per symptom-free person (QALY) gained, compared to WLC. This probability increased to 80% at a societal willingness-to-pay of €20,000 per QALY gained. Taking the employer’s perspective, the digital intervention showed a probability for a positive return on investment of 78%.

CONCLUSIONS

Digital preventive stress management for employees appears to be cost-effective societally and provides a favorable return-on-investment for employers.

CLINICALTRIAL

German clinical trials register (DRKS00005699)

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3